Using AI tools to improve diagnosis of respiratory infections through medical imaging
Official title: Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
Run by Huashan Hospital · NCT06553911 · Data updated 2026-11-12
This study is testing whether using artificial intelligence with medical imaging can help doctors diagnose respiratory infections like pneumonia more accurately and quickly.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Year to 90 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Huashan Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | April 1, 2022 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2026 |
| Registry record updated | August 14, 2024 |
| Trial ID | NCT06553911 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 1 to 90 who exhibit symptoms of respiratory tract infections and have relevant imaging data.
✕Probably not a fit
Patients with severe artifacts in medical images or those with concurrent pulmonary edema may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study explores the use of artificial intelligence diagnostic tools to enhance the accuracy and efficiency of medical imaging for respiratory infectious diseases. By integrating AI into the diagnostic process, the initiative aims to reduce the time healthcare professionals spend reviewing images and improve the sensitivity and specificity of pneumonia detection. The goal is to facilitate early identification and effective management of respiratory infections, particularly at the grassroots level. Participants will undergo imaging examinations, and their results will be analyzed using AI technology to assess its efficacy in clinical settings.
Why it matters
Potential benefit: If successful, this approach could significantly improve early diagnosis and treatment of respiratory infections, leading to better patient outcomes.
How similar studies have gone: Other studies have shown promise in using AI for medical imaging, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 1-90 years old, gender not specified. 2. Exhibits symptoms of respiratory tract infection 3. Must have etiological examination results 4. Must have imaging data; Exclusion Criteria: 1. Severe artifacts in medical images 2. Clinical diagnosis indicates concurrent pulmonary edema 3. Dual review results in unclear diagnosis or potential misdiagnosis 4. Other situations that may cause difficulties in reading the films, or as determined by the researcher, the study participant is deemed unsuitable for enrollment.
Where it's running
-
Huashan Hospital
Shanghai, China Recruiting
Study contacts
- Study coordinator: Wenhong Zhang
- Email: zhangwenhong@fudan.edu.cn
- Phone: (86)52889999
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New diagnostic strategy for respiratory infections in fever clinics
This study is testing a new way to quickly diagnose respiratory infections in patients with fever and cough to help doctors provide better care.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
AI-assisted and traditional workflows for admission diagnosis and management planning
This trial tests whether an AI-agent workflow helps doctors make better admission diagnoses and care plans on simulated cases, compared with plain AI-assisted and traditional workflows.
-
Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency
This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.
-
Timing of AI Help in Chest X-Rays: Does When AI Becomes Visible Change How Clinicians Read Images?
Doctors test chest X-ray interpretation with AI information shown either before or after they start reviewing the image to see how timing affects their search patterns and decisions.
-
Does AI-based cephalometric tracing match digital manual tracing for orthodontic measurements?
This study tests whether AI-powered cephalometric analysis can produce measurements similar to traditional digital tracing in 100 patient radiographs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.